Copyright Reports & Markets. All rights reserved.

Global and China Prenatal and New-born Genetic Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prenatal and New-born Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 PCR
    • 1.2.3 FISH
    • 1.2.4 aCGH
    • 1.2.5 NIPT
    • 1.2.6 MSS
  • 1.3 Market by Application
    • 1.3.1 Global Prenatal and New-born Genetic Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Prenatal and New-born Genetic Testing Market Perspective (2015-2026)
  • 2.2 Global Prenatal and New-born Genetic Testing Growth Trends by Regions
    • 2.2.1 Prenatal and New-born Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prenatal and New-born Genetic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prenatal and New-born Genetic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prenatal and New-born Genetic Testing Players by Market Size
    • 3.1.1 Global Top Prenatal and New-born Genetic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Prenatal and New-born Genetic Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Prenatal and New-born Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Prenatal and New-born Genetic Testing Revenue
  • 3.4 Global Prenatal and New-born Genetic Testing Market Concentration Ratio
    • 3.4.1 Global Prenatal and New-born Genetic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prenatal and New-born Genetic Testing Revenue in 2019
  • 3.5 Key Players Prenatal and New-born Genetic Testing Area Served
  • 3.6 Key Players Prenatal and New-born Genetic Testing Product Solution and Service
  • 3.7 Date of Enter into Prenatal and New-born Genetic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prenatal and New-born Genetic Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Prenatal and New-born Genetic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Prenatal and New-born Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Prenatal and New-born Genetic Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Prenatal and New-born Genetic Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Prenatal and New-born Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prenatal and New-born Genetic Testing Market Size (2015-2026)
  • 6.2 North America Prenatal and New-born Genetic Testing Market Size by Type (2015-2020)
  • 6.3 North America Prenatal and New-born Genetic Testing Market Size by Application (2015-2020)
  • 6.4 North America Prenatal and New-born Genetic Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Prenatal and New-born Genetic Testing Market Size (2015-2026)
  • 7.2 Europe Prenatal and New-born Genetic Testing Market Size by Type (2015-2020)
  • 7.3 Europe Prenatal and New-born Genetic Testing Market Size by Application (2015-2020)
  • 7.4 Europe Prenatal and New-born Genetic Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Prenatal and New-born Genetic Testing Market Size (2015-2026)
  • 8.2 China Prenatal and New-born Genetic Testing Market Size by Type (2015-2020)
  • 8.3 China Prenatal and New-born Genetic Testing Market Size by Application (2015-2020)
  • 8.4 China Prenatal and New-born Genetic Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Prenatal and New-born Genetic Testing Market Size (2015-2026)
  • 9.2 Japan Prenatal and New-born Genetic Testing Market Size by Type (2015-2020)
  • 9.3 Japan Prenatal and New-born Genetic Testing Market Size by Application (2015-2020)
  • 9.4 Japan Prenatal and New-born Genetic Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Prenatal and New-born Genetic Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Prenatal and New-born Genetic Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Prenatal and New-born Genetic Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Prenatal and New-born Genetic Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Agilent Technologies, Inc.
    • 11.1.1 Agilent Technologies, Inc. Company Details
    • 11.1.2 Agilent Technologies, Inc. Business Overview
    • 11.1.3 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Introduction
    • 11.1.4 Agilent Technologies, Inc. Revenue in Prenatal and New-born Genetic Testing Business (2015-2020))
    • 11.1.5 Agilent Technologies, Inc. Recent Development
  • 11.2 Bio-Rad Laboratories, Inc.
    • 11.2.1 Bio-Rad Laboratories, Inc. Company Details
    • 11.2.2 Bio-Rad Laboratories, Inc. Business Overview
    • 11.2.3 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Introduction
    • 11.2.4 Bio-Rad Laboratories, Inc. Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.2.5 Bio-Rad Laboratories, Inc. Recent Development
  • 11.3 Natera, Inc.
    • 11.3.1 Natera, Inc. Company Details
    • 11.3.2 Natera, Inc. Business Overview
    • 11.3.3 Natera, Inc. Prenatal and New-born Genetic Testing Introduction
    • 11.3.4 Natera, Inc. Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.3.5 Natera, Inc. Recent Development
  • 11.4 Illumina, Inc.
    • 11.4.1 Illumina, Inc. Company Details
    • 11.4.2 Illumina, Inc. Business Overview
    • 11.4.3 Illumina, Inc. Prenatal and New-born Genetic Testing Introduction
    • 11.4.4 Illumina, Inc. Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.4.5 Illumina, Inc. Recent Development
  • 11.5 Ariosa Diagnostics
    • 11.5.1 Ariosa Diagnostics Company Details
    • 11.5.2 Ariosa Diagnostics Business Overview
    • 11.5.3 Ariosa Diagnostics Prenatal and New-born Genetic Testing Introduction
    • 11.5.4 Ariosa Diagnostics Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.5.5 Ariosa Diagnostics Recent Development
  • 11.6 Perkin Elmer
    • 11.6.1 Perkin Elmer Company Details
    • 11.6.2 Perkin Elmer Business Overview
    • 11.6.3 Perkin Elmer Prenatal and New-born Genetic Testing Introduction
    • 11.6.4 Perkin Elmer Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.6.5 Perkin Elmer Recent Development
  • 11.7 Verinata Health
    • 11.7.1 Verinata Health Company Details
    • 11.7.2 Verinata Health Business Overview
    • 11.7.3 Verinata Health Prenatal and New-born Genetic Testing Introduction
    • 11.7.4 Verinata Health Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.7.5 Verinata Health Recent Development
  • 11.8 Sequenom, Inc.
    • 11.8.1 Sequenom, Inc. Company Details
    • 11.8.2 Sequenom, Inc. Business Overview
    • 11.8.3 Sequenom, Inc. Prenatal and New-born Genetic Testing Introduction
    • 11.8.4 Sequenom, Inc. Revenue in Prenatal and New-born Genetic Testing Business (2015-2020)
    • 11.8.5 Sequenom, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Prenatal and New-born Genetic Testing Scope and Market Size
    Prenatal and New-born Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prenatal and New-born Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    PCR
    FISH
    aCGH
    NIPT
    MSS

    Market segment by Application, split into
    Hospital
    Clinic
    Others

    Based on regional and country-level analysis, the Prenatal and New-born Genetic Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Prenatal and New-born Genetic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Agilent Technologies, Inc.
    Bio-Rad Laboratories, Inc.
    Natera, Inc.
    Illumina, Inc.
    Ariosa Diagnostics
    Perkin Elmer
    Verinata Health
    Sequenom, Inc.

    Buy now